Impaired healing of nitrogen mustard wounds in CXCR2 null mice

被引:39
作者
Milatovic, S
Nanney, LB
Yu, YC
White, JR
Richmond, A
机构
[1] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Plast Surg & Cell & Dev Biol, Nashville, TN 37232 USA
[3] Dept Vet Affairs, Nashville, TN USA
[4] GlaxoSmithKline, King Of Prussia, PA USA
关键词
D O I
10.1046/j.1524-475X.2003.11310.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To examine the significance of chemokine activation of CXCR2 in wound healing after chemical burn, cutaneous injury was created by topical application of nitrogen mustard on CXCR2 wild type (+/+), heterozygous (+/-), and knockout (-/-) mice. Wounds were analyzed histologically for neutrophil and monocyte infiltration and for reepithelialization at postwound days 4, 7, and 10. Neutrophil recruitment to the wound site was reduced through postwound day 7 in CXCR2 -/- mice as indicated by myeloperoxidase assay and by visual quantitation. Because there is always concern that mice with targeted deletion of a specific receptor may undergo developmental adaptations to offset the loss of the receptor, we also accessed chemical wound repair in the presence of a small molecule antagonist of CXCR2. Dietary supplementation with a CXCR2 antagonist (SB-265610) during the wound repair process also markedly delayed healing parameters in CXCR2 +/+ mice, even greater than treatment with glucocorticoids. These parallel studies further establish that mice deficient in CXCR2 function exhibit delayed cutaneous wound healing that may be primarily linked to impaired neutrophil recruitment after chemical burn with nitrogen mustard. Thus, there may be a potential therapeutic benefit of treating nitrogen mustard-induced skin lesions with agonists of CXCR2 to facilitate the wound repair process.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 20 条
[1]   AGENTS OF CHEMICAL WARFARE - SULFUR MUSTARD [J].
BORAK, J ;
SIDELL, FR .
ANNALS OF EMERGENCY MEDICINE, 1992, 21 (03) :303-308
[2]   Delayed wound healing in CXCR2 knockout mice [J].
Devalaraja, RM ;
Nanney, LB ;
Qian, QH ;
Du, JG ;
Yu, YC ;
Devalaraja, MN ;
Richmond, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :234-244
[3]   MIP-1α as a critical macrophage chemoattractant in murine wound repair [J].
DiPietro, LA ;
Burdick, M ;
Low, QE ;
Kunkel, SL ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1693-1698
[4]   A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas [J].
Estève, E ;
Bagot, M ;
Joly, P ;
Souteyrand, P ;
Beylot-Barry, M ;
Vaillant, L ;
Delaunay, M ;
Avril, MF ;
Laroche, L ;
Grange, F ;
Thomine, E ;
Wechsler, J .
ARCHIVES OF DERMATOLOGY, 1999, 135 (11) :1349-1353
[5]   The CXC chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure [J].
Feugate, JE ;
Li, QJ ;
Wong, L ;
Martins-Green, M .
JOURNAL OF CELL BIOLOGY, 2002, 156 (01) :161-172
[6]   Evaluation of a 1-h exposure time to mechlorethamine in patients undergoing topical treatment [J].
Foulc, P ;
Evrard, V ;
Dalac, S ;
Guillot, B ;
Delaunay, M ;
Verret, JL ;
Dréno, B .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (05) :926-930
[7]  
Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
[8]   Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice [J].
Hubner, G ;
Brauchle, M ;
Smola, H ;
Madlener, M ;
Fassler, R ;
Werner, S .
CYTOKINE, 1996, 8 (07) :548-556
[9]   Interleukin-8 levels and activity in delayed-healing human thermal wounds [J].
Iocono, JA ;
Colleran, KR ;
Remick, DG ;
Gillespie, BW ;
Ehrlich, HP ;
Garner, WL .
WOUND REPAIR AND REGENERATION, 2000, 8 (03) :216-225
[10]  
LEESON TS, 1988, GEN HISTOLOGICAL PRI, P206